VP OF BUSINESS DEVELOPMENT Professional Overview Accomplished Business Development executive 7 years experience life science startups clinical research organizations. I also entrepreneurial spirit co-founder data analytics company, financial background Master's Bentley University. Education December 2012 Finance McCallum Graduate School Bentley University Finance Extensive case-based exercises capital budgeting, corporate finance, marketing sizing, equities, bonds, common financial covenants, options. Experience valuations including risk-adjusted net present value using WACC CAPM comparables May 2011 Bachelor Science Economics Finance Bentley University Cum Laude Economics Finance Experience 01/2016 Current VP Business Development Company Name － City State PainQx (PQX) diagnostic/software company developed next generation approach objectively measure pain humans decoding neural activity. Incorporated PQX platform six clinical trials used pain biomarker gauge efficacy experimental therapeutics. Raised $500k angel groups venture funds. Identified joint venture partner China leading $1M investment. Developed economic model demonstrating PQX technology reduces costs health care providers converting poorly managed pain patients well-managed pain patients, saving $8,500 per patient. Created financials statements including income statement, balance sheet, cash flow justify capital raise share investors. Centralized contacts, alliances, investors CRM system streamlining business development. Developed investor facing business development presentations. Formed strategic alliance Evoke Neurosciences incorporate EEG headset PainQx platform providing turnkey solution clinical research sponsors. Coordinated bottoms upmarket survey interviewed 100 physicians validate PainQx value proposition identify new markets platform. Sourced, pitched grant National Institue Drug Abuse (NIDA) recognizing PainQx one 10 companies national could address opioid epidemic. Put together SBIR Fast Track Application reviewed NIDA. 06/2012 01/2016 Co-Founder VP Business Development Company Name － City State LSN tracks funding partnering preferences 5,000 investors strategic partners actively interviewing 90-day rolling cycle. This information allows entrepreneurs identify investors strategic meet fundraising partnering needs. Since inception LSN generated $4M revenue, 2016 revenue $3M. In 2015, LSN launched broker-dealer, Boston Innovation Capital, execute fundraising campaigns $5M $20M. Oversee aspects operation sales, financial projections, IT, management, marketing. Grew LSN team 22 employees: 7 business development representatives, 6 researchers, 4 conference representatives, 2 marketers. Created pitch decks, executive summaries, websites twelve biotech/medtech companies, resulting increased investor responsiveness. Utilize SalesForce.com host LSN's back end data linked established graphical user interface, saving $1M R&D costs. Deep knowledge database information systems including profile structuring, data segmentation aggregation, filtering. Personally sourced, pitched, closed $1M consulting data services Big Pharma, CROs, emerging biotech/medtech companies. Helped create fundraising strategy thirty-four biotech/medtech companies including EIP Pharma, Hsiri Therapeutics JB Therapeutics (Corbus Pharma). Built personal network 1,000 life science investors, life science entrepreneurs, investment banks, family offices, big pharma/med-tech executives. 02/2011 07/2012 Abpro specializes generation custom monoclonal antibodies. The foundation Abpro's techn Company Name － City State Abpro specializes generation custom monoclonal antibodies. The foundation Abpro's technology HTP platform, genetically engineered mouse boosted immune system, enabling mouse broader epitope spread facilitating generation antibodies traditionally difficult targets GPCR's, 100% homologous target. Personally closed $1.6M new business revenue. Part business development team grew sales $700,000 2010, $2.2M 2011, $4.0M 2012. Participated financing campaign aimed raise $3.4M debt various banks mezzanine debt funds. Modeled present value debt based offerings provide investment decisions upper management. Developed company's first financial model tied together income, balance sheet cash flow statements. This model used plan future financing needs well develop company's long-term budgetary constraints. Built implemented inventory tracking system streamline operations leading 30% reduction production delays. Created automated system crawled three-hundred scientific journals gathering contact information authors. This information led creation database 100,000 contacts use targeted email campaign. Interests USA (14 years), London (6 years), Colombia (5 years), China (2 years). Languages Native Speaker English Spanish Skills streamline, approach, balance sheet, bonds, budgeting, business development, cash flow, clinical research, clinical trials, com, consulting, corporate finance, CRM, database, email, English, equities, Fast, financials, financing, financial, fundraising, funds, graphical user interface, information systems, Innovation, inventory, marketing, network, neural, next, presentations, Speaker, sales, scientific, Spanish, strategy, strategic, websites Additional Information International Experience: USA (14 years), London (6 years), Colombia (5 years), China (2 years).